Arkadios Wealth Advisors
- SEC CIK
- 0001800798
- Latest filing
- Aug 10, 2026
CRSP holding history
CRISPR Therapeutics AG in every 13F filed by Arkadios Wealth Advisors, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CRSP overviewAll 13F holders of CRSPFull Q2 2026 holdings
- Shares (Q2 2026)
- 10,487
- Value
- $572.0K
- % of portfolio
- <0.1%
- Quarters held
- 21
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 10,487 | $572.0K | <0.1% | +1,071+11.4% | Added | Holders |
| Q1 2026 | 9,416 | $447.9K | <0.1% | −10.0% | Reduced | Holders |
| Q4 2025 | 9,417 | $493.8K | <0.1% | −951−9.2% | Reduced | Holders |
| Q3 2025 | 10,368 | $672.0K | <0.1% | −247−2.3% | Reduced | Holders |
| Q2 2025 | 10,615 | $516.3K | <0.1% | −623−5.5% | Reduced | Holders |
| Q1 2025 | 11,238 | $382.4K | <0.1% | −923−7.6% | Reduced | Holders |
| Q4 2024 | 12,161 | $478.7K | <0.1% | +866+7.7% | Added | Holders |
| Q3 2024 | 11,295 | $530.6K | <0.1% | +524+4.9% | Added | Holders |
| Q2 2024 | 10,771 | $581.7K | <0.1% | −96−0.9% | Reduced | Holders |
| Q1 2024 | 10,867 | $740.7K | 0.1% | −158−1.4% | Reduced | Holders |
| Q4 2023 | 11,025 | $690.2K | 0.1% | −235−2.1% | Reduced | Holders |
| Q3 2023 | 11,260 | $511.1K | <0.1% | +130+1.2% | Added | Holders |
| Q2 2023 | 11,130 | $624.8K | 0.1% | −558−4.8% | Reduced | Holders |
| Q1 2023 | 11,688 | $528.6K | 0.1% | −44−0.4% | Reduced | Holders |
| Q4 2022 | 11,732 | $476.9K | 0.1% | −1,302−10.0% | Reduced | Holders |
| Q3 2022 | 13,034 | $852.0K | 0.1% | −216−1.6% | Reduced | Holders |
| Q2 2022 | 13,250 | $805.0K | 0.1% | +26+0.2% | Added | Holders |
| Q1 2022 | 13,224 | $830.0K | 0.1% | +404+3.2% | Added | Holders |
| Q4 2021 | 12,820 | $971.0K | 0.1% | +12,650+7,441.2% | Added | Holders |
| Q3 2021 | 170 | $19.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 170 | $27.0K | <0.1% | +170 | New | Holders |